Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention?
Recently, we have experienced cerebrovascular embolic events in 2 consecutive patients in our outpatient clinic. Accordingly, we want to share our comments with literature on these 2 patients. Both patients had newly diagnosed left ventricular (LV) dysfunction, sinus rhythm, and cerebrovascular event within the first week after initiation of heart failure treatment. Although, our cases are not enough to make a general statement or conclusion, we can recommend that patients with newly diagnosed severe LV dysfunction with normal sinus rhythm and without echocardiographically visible thrombus should also be closely followed up for thromboembolic complications at least during the first weeks of congestive heart failure treatment.
Yetkin
Ertan
E
Department of Cardiology, International Medical Center, Mersin, Turkey. ertanyetkin@hotmail.com
Topal
Ergun
E
Yanik
Ahmet
A
Ozten
Mahmut
M
D000925:Anticoagulants / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000150:complications* / Q000628:therapy; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000503:physiopathology
D000925:Anticoagulants